Sign in

CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company

Opus Genetics, Inc.

Sign in to watch
Ticker
IRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
113516358
Phone
(984) 884-6030
Business address
8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
Former names
Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
  1. 8-K Event Executive or director change
  2. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
  3. ARS Other Annual Report to Security Holders
  4. DEF 14A Proxy Proxy Statement
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. UPLOAD Other SEC-generated Letter
  10. 144 Insider Sale of Securities
  11. S-3 Offering Registration Statement
  12. PRE 14A Proxy Proxy Statement (Preliminary)
  13. 10-K Report Annual Report
  14. 8-K Event Results of operations
  15. 8-K Event Material agreement · Results of operations · Unregistered share sale · Bylaws or fiscal year change · Other events
  16. 4 Insider Changes in Ownership
  17. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  18. SCHEDULE 13G Stake Statement of Beneficial Ownership
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 4 Insider Changes in Ownership

Page 5 of 54 · 1,070 filings